Stewards of critical care
Innoviva Specialty Therapeutics (ljpc.com) scores 56 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 3rd percentile of 17178 Healthcare brands.
Innoviva Specialty Therapeutics is a healthcare company headquartered in San Diego, United States, founded in 1989. It develops and delivers therapies for patients with serious, life-threatening conditions in critical care and infectious disease. The company positions itself as a dedicated steward of critical care, aiming to address urgent, unmet medical needs. Its work targets healthcare providers and patients in critical care and infectious disease settings, emphasizing innovation in treatment options for high unmet medical need areas.
| Brand Name | Innoviva Specialty Therapeutics |
|---|---|
| Domain | ljpc.com |
| Industry | Healthcare |
| Founded | 1989 |
| Headquarters | San Diego |
| Parent Company / Owner | Innoviva, Inc. |
| Main Competitors | Paratek Pharmaceuticals (75/100), Melinta Therapeutics (74/100), Spero Therapeutics (75/100), Cidara Therapeutics, Entasis Therapeutics (65/100), Nabriva Therapeutics (53/100) |
Moz Domain Authority 37/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Innoviva Specialty Therapeutics develops and delivers innovative therapies for patients in critical care and infectious disease" (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on X (Twitter), LinkedIn, Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Innoviva Specialty Therapeutics?", Claude could identify the brand as of October 2026. Innoviva Specialty Therapeutics is the renamed La Jolla Pharmaceutical Company, acquired by Innoviva in 2022, and it focuses on hospital and specialty products, most notably GIAPREZA (angiotensin II) for critically ill patients with septic or other distributive shock. Best known for GIAPREZA, a vasopressor used to treat severe hypotension in septic shock.
When asked "Best brands similar to Innoviva Specialty Therapeutics?", Claude would recommend Innoviva Specialty Therapeutics as of October 2026. If someone asked about specialty critical care or hospital pharma brands, GIAPREZA and this company's niche in vasopressor therapy would be relevant to mention.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Innoviva Specialty Therapeutics's main competitors in Healthcare: Paratek Pharmaceuticals (75/100), Melinta Therapeutics (74/100), Spero Therapeutics (75/100), Entasis Therapeutics (65/100), Nabriva Therapeutics (53/100).
Sources: Brand Analyzer scan
Innoviva Specialty Therapeutics has low AI-search visibility, scoring 21/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 12, recommendation 30). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Innoviva Specialty Therapeutics was founded in 1989. Innoviva Specialty Therapeutics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Innoviva Specialty Therapeutics is headquartered in San Diego. Innoviva Specialty Therapeutics operates in the Healthcare category.
Sources: Wikidata
Innoviva Specialty Therapeutics scores 30/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Innoviva Specialty Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Innoviva Specialty Therapeutics is a healthcare company based in San Diego, United States, founded in 1989. It is part of the Innoviva, Inc. corporate family and focuses on developing and delivering therapies for patients facing serious, life-threatening conditions, particularly within critical care and infectious disease.
Innoviva Specialty Therapeutics' offerings are used by healthcare providers and patients dealing with serious, life-threatening conditions, specifically within critical care and infectious disease settings.
Innoviva Specialty Therapeutics scores 21/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Innoviva Specialty Therapeutics has a weak AI-visibility profile at 21/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (30/100) and its weakest is trust (12/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and thin schema.org structured data. In a live check, Claude could already identify Innoviva Specialty Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Innoviva Specialty Therapeutics: Kuraray Noritake Dental (56/100), 金山云 (Kingsoft Cloud) (56/100), Rhapsody (56/100), MarinHealth (56/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.